https://www.avient.com/sites/default/files/2022-12/Mevopur Healthcare Colorants and Formulations for Needle Hubs Application Bulletin.pdf
KEY CHARACTERISTICS
• Manufactured at four ISO 13485 certified sites,
providing global consistency and increased
security of supply
• Documented change control beyond CAS
number, reducing risk of change
• Non-phthalate and formulated without
animal-derived substances
• Color can be combined with additives to
enhance performance and protection
REGULATORY SUPPORT
• Raw materials tested to:
- ISO 10993-1 and USP biological
evaluation
- European Pharmacopeia 3.1.3/3.1.5
(polyolefin)
- USP (polyethylene)
- ICH Q3D elemental impurities
• Registered Device Master File
• Food contact established with FDA/EU*
NOMINAL
OUTSIDE
DIAMETER OF
NEEDLE (MM)
COLOR
DESCRIPTION RAL PANTONE
TRANSPARENT
PRODUCT CODE
OPAQUE
PRODUCT
CODE
0.4 Medium Grey 7035 423 C PP7M665125 PP7M665127
0.45 Brown 8017 7588 C PP8M665294 PP8M665296
0.5 Orange 2003 173 C PP2M665298 PP2M665300
0.55 Medium Purple 4005 7676 C PP4M665290 PP4M665292
0.6 Deep Blue 5010 288 C PP5M665894 PP5M665896
0.7 Black 9005 Black C PP9M664950 PP9M664952
0.8 Deep Green 6001 7483 C PP6M665687 PP6M665689
0.9 Yellow 1021 115 C PP1M665211 PP1M665213
1.1 Cream 1015 7401 C PP0M665290 PP0M665292
1.2 Pink 3015 502 C PE3M665725 PP3M665727
Healthcare use limitations apply—see below.
https://www.avient.com/sites/default/files/2020-08/stan-tone-wdn-product-bulletin.pdf
%
Solids
Color
Index
pH
Typical
Weight
Lbs/Gal
WHITE
10WDN03
Titanium Dioxide,
Rutile
60 73 PW-6 9 16.7
YELLOW
12WDN01 Diarylide AAOT GS 35 43 PY-14 8.8 9.4
12WDN02 Diarylide HR RS 37 44 PY-83 8.8 9.6
12WDN03 Arylide GY RS 38 45 PY-74 8.8 9.2
81WDN01 Iron Oxide 55 63 PY-42 8.8 14.5
ORANGE
15WDN01 Pryazolone YS 40 45 PO-13 8.8 9.2
15WDN03 Dianisidine RS 35 37 PO-16 8.8 9.2
15WDN06 DNA Orange RS 31 43 PO-5 8.8 9.7
RED
22WDN01 Lithol Rubine BS 33 40 PR-57 8.8 9.8
21WDN01 Naphthol BS 35 43 N/A 8.8 9.5
25WDN01 Red 2B, Ca BS 34 41 PR-48:2 8.8 9.6
28WDN01 Red 2B, Ba YS 36 44 PR-48:1 8.8 9.5
82WDN02 Iron Oxide 57 66 PR-101 8.8 16
BLUE
40WDN01 Phthalocyanine RS 35 46 PB-15 8.8 9.7
40WDN03 Phthalocyanine GS 38 43 PB-15:3 8.8 9.8
GREEN
WDN-27822 Phthalocyanine BS 42 53 PG-7 8.8 10.5
VIOLET/MAGENTA
24WDN02 Carbazole 35 48 PV-23 8.8 9.6
24WDN03 Quinacridone 31 39 PV-19 8.8 9.6
24WDN05 Quinacridone 30 41 PR-122 8.8 10
BLACK
90WDN01 Carbon Black 45 49 PB-7 8.8 9.3
WDN
RS = Red Shade YS = Yellow Shade BS = Blue Shade GS = Green Shade HR = Heat-Resistant
www.avient.com
Copyright © 2020, Avient Corporation.
https://www.avient.com/sites/default/files/2024-08/Automotive General Design Technology Guide.pdf
http://www.avient.com
METALLIC
Solid Metal
METALLIC
Various Shades
Click here to return to the Applications Chart
METALLIC
Bright Colors
METALLIC
Larger Flakes
Click here to return to the Applications Chart
LASER MARK PATTERN
on Metallic
LASER MARKING
Click here to return to the Applications Chart
GRANITE
Specks
GRANITE
Fibers
Click here to return to the Applications Chart
MARBLE
TRANSLUCENT/
TINT/FLUORESCENT
Click here to return to the Applications Chart
LIGHT DIFFUSION
ONCOLOR™ REC POLYMER COLORANTS
Color concentrate derived from recycled content such as end-of-life tires
• Sustainable alternative to virgin carbon black
• Retains performance characteristics of traditional carbon black
• Available for multiple resins and custom solutions
Click here to return to the Applications Chart
Visit us at
avient.com
http://www.avient.com
https://www.avient.com/sites/default/files/2022-09/Avient Pro Forma Financial Information.pdf
AVIENT CORPORATION
P R O F O R M A F I N A N C I A L S F O R D Y N E E M A
A C Q U I S I T I O N A N D D I S T R I B U T I O N A S
D I S C O N T I N U E D O P E R A T I O N S
(NYSE: AVNT)
S E P T E M B E R 2 7 , 2 0 2 2
DISCLAIMER
Forward-Looking Statements
Certain statements contained in or incorporated by reference into this presentation constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.
Additionally, Adjusted EPS excludes the impact of special
items and amortization expense associated with intangible assets.
2
PRO FORMA 2021 TO 2022 BRIDGE
3
2021 EPS from Continuing Operations 1.69$
Pro Forma & Special Items 1.33
Proforma 2021 Adjusted EPS 3.02$
FX Impact (0.22)
China Lockdowns / Russia Import Sales (0.24)
Outdoor High Performance (0.13)
Dyneema 0.06
Color, Additives and Inks 0.38
Legacy Specialty Engineered Materials 0.22
Other 0.01
Proforma 2022 Adjusted EPS 3.10$
Constant Currency Sales
Sales
COLOR, ADDITIVES AND INKS
Q1 Q2 Q3 Q4 FY
4%
Q1 Q2 Q3 Q4 FY
4%
7% (4%) (9%)
6% (10%)
0% 1%
2%
Constant currency reflects prior year results restated at current year foreign exchange rates
Q1 Q2 Q3 Q4 FY Q1 Q2 Q3 Q4 FY
7%
10% 4% (3%)
12% (6%)
5% 6%
9%
610 650 624 649 587 565 581 526
2,402 2,390
589 650 589 649 543 565 545 526
2,266 2,390
116 121 112 119 93 95 88 79
409 414
113 121 106 119 87 95 84 79
390 414
Constant Currency EBITDA
EBITDA
10%
4
Constant Currency EBITDA
Sales
Q1 Q2 Q3 Q4 FY
(1%)
PRO FORMA SPECIALTY ENGINEERED MATERIALS
Q1 Q2 Q3 Q4 FY
16%8% (8%) (8%)
3% (6%) (6%)
(2%) 2%
EBITDA
Constant Currency Sales
Constant currency reflects prior year results restated at current year foreign exchange rates
Q1 Q2 Q3 Q4 FY
4%
Q1 Q2 Q3 Q4 FY
20%12% (1%) (2%)
5% (1%) (2%)
3% 6%
314 338 348 343 325 300 321 295
1,308 1,276
303 338 329 343 303 300 301 295
1,236 1,276
67 78 75 77 70 66 66 62
278 283
65 78 73 77 67 66 63 62
268 283
5
Constant Currency Adjusted EPS
Adjusted EPS
PRO FORMA AVIENT
Q1 Q2 Q3 Q4 FY
10% (3%) (21%)
3%
Q1 Q2 Q3 Q4 FY Q1 Q2 Q3 Q4 FY
9% 5%
7% (5%) (9%)
(1%)
(1%) (12%)
1%
Sales
Constant Currency Sales
Constant currency reflects prior year results restated at current year foreign exchange rates
Q1 Q2 Q3 Q4 FY
17% 8% (14%)
11%
Q1 Q2 Q3 Q4 FY Q1 Q2 Q3 Q4 FY
14% 10%
11% 2% (3%)
5%
8% (5%)
7%
EBITDA
Constant Currency EBITDA
925 987 973 992 912 867 902 823
3,712 3,669
893 987 919 992 847 867 845 823
3,504 3,669
161 176 164 172 142 141 133 117
600 606
155 176 157 172 131 141 123 117
566 6068%
2%
0.84 0.98 0.87 0.96 0.70 0.68 0.61 0.48
3.02 3.10
0.79 0.98 0.82 0.96 0.63 0.68 0.56 0.48
2.80 3.10
17%
24%
6
Three Months Ended
March 31, 2022
Three Months Ended
March 31, 2021
Reconciliation to Condensed Consolidated Statements of Income Avient EPS Avient EPS
Net income from continuing operations $ 64.7 $ 60.4
Net income attributable to noncontrolling interests (0.3) (0.4)
Net income from continuing operations attributable to Avient shareholders $ 64.4 $ 0.70 $ 60.0 $ 0.65
Special items, after tax $ 6.4 $ 0.07 $ 2.6 $ 0.03
APM pro forma adjustments 2.6 0.03 (3.1) (0.03)
Amortization expense, after tax 17.4 0.19 17.9 0.19
Adjusted pro forma net income / EPS $ 90.8 $ 0.98 $ 77.4 $ 0.84
Weighted average diluted shares 92.3 92.2
Three Months Ended
June 30, 2022
Three Months Ended
June 30, 2021
Reconciliation to Condensed Consolidated Statements of Income Avient EPS Avient EPS
Net income from continuing operations $ 62.8 $ 50.2
Net income attributable to noncontrolling interests — (0.6)
Net income from continuing operations attributable to Avient shareholders $ 62.8 $ 0.68 $ 49.6 $ 0.54
Special items, after tax $ 3.2 $ 0.03 $ 11.7 $ 0.13
APM pro forma adjustments 5.2 0.06 1.4 0.02
Amortization expense, after tax 17.2 0.19 17.8 0.19
Adjusted pro forma net income / EPS $ 88.4 $ 0.96 $ 80.5 $ 0.87
Weighted average diluted shares 92.1 92.4
Three Months Ended
September 30, 2021
Reconciliation to Condensed Consolidated Statements of Income Avient EPS
Net income from continuing operations $ 33.4
Net income attributable to noncontrolling interests 0.3
Net income from continuing operations attributable to Avient shareholders $ 33.7 $ 0.37
Special items, after tax $ 11.7 $ 0.13
APM pro forma adjustments 1.5 0.02
Amortization expense, after tax 17.6 0.19
Adjusted pro forma net income / EPS $ 64.5 $ 0.70
Weighted average diluted shares 92.2
Adjusted EPS may not recalculate due to rounding.
1
Three Months Ended
December 31, 2021
Year Ended
December 31, 2021
Reconciliation to Condensed Consolidated Statements of Income Avient EPS Avient EPS
Net income from continuing operations $ 11.2 $ 155.2
Net income attributable to noncontrolling interests 0.9 0.2
Net income from continuing operations attributable to Avient shareholders $ 12.1 $ 0.13 $ 155.4 $ 1.69
Special items, after tax $ 24.0 $ 0.26 $ 50.0 $ 0.54
APM pro forma adjustments 2.5 0.03 1.6 0.02
Amortization expense, after tax 17.8 0.19 71.1 0.77
Adjusted pro forma net income / EPS $ 56.4 $ 0.61 $ 278.1 $ 3.02
Weighted average diluted shares 92.4 92.1
Reconciliation of Color, Additives and Inks EBITDA
Q1 2021 Q2 2021 Q3 2021 Q4 2021 YTD 2021 Q1 2022 Q2 2022
Operating
Income 88.8 86.3 66.8 61.2 303.1 94.5 93.6
Depreciation and
amortization 27.4 25.3 26.6 26.4 105.7 26.0 25.9
EBITDA $ 116.2 $ 111.6 $ 93.4 $ 87.6 $ 408.8 $ 120.5 $ 119.5
Reconciliation of Specialty Engineered Materials EBITDA
Q1 2021 Q2 2021 Q3 2021
SEM
Pro
forma
APM
Pro
forma
SEM SEM
Pro
forma
APM
Pro
forma
SEM SEM
Pro
forma
APM
Pro
forma
SEM
Operating Income 32.6 9.1 41.7 35.8 13.9 49.7 30.0 15.2 45.2
Depreciation and
amortization 7.8 17.5 25.3 8.1 17.3 25.4 7.9 17.1 25.0
EBITDA $ 40.4 $ 26.6 $ 67.0 $ 43.9 $ 31.2 $ 75.1 $ 37.9 $ 32.3 $ 70.2
Reconciliation of Specialty Engineered Materials EBITDA
Q4 2021 YTD 2021
SEM
Pro
forma
APM
Pro
forma
SEM SEM
Pro
forma
APM
Pro
forma
SEM
Operating Income 27.1 11.7 38.8 125.5 49.9 175.4
Depreciation and amortization 8.0 18.9 26.9 31.8 70.8 102.6
EBITDA $ 35.1 $ 30.6 $ 65.7 $ 157.3 $ 120.7 $ 278.0
2
Reconciliation of Specialty Engineered Materials EBITDA
Q1 2022 Q2 2022
SEM
Pro
forma
APM
Pro
forma
SEM SEM
Pro
forma
APM
Pro
forma
SEM
Operating Income 38.3 15.4 53.7 35.2 17.7 52.9
Depreciation and amortization 7.8 16.6 24.4 7.7 16.6 24.3
EBITDA $ 46.1 $ 32.0 $ 78.1 $ 42.9 $ 34.3 $ 77.2
Reconciliation of Avient consolidated pro forma EBITDA
Q1 2021 Q2 2021 Q3 2021
Avient
Pro
forma
APM
Pro
forma
Avient Avient
Pro
forma
APM
Pro
forma
Avient Avient
Pro
forma
APM
Pro
forma
Avient
Net income from
continuing operations 60.4 (3.1) 57.3 50.2 1.4 51.6 33.4 1.5 34.9
Income tax expense 16.3 1.1 17.4 13.8 1.3 15.1 2.0 2.5 4.5
Interest expense 19.3 11.1 30.4 19.5 11.2 30.7 19.0 11.2 30.2
Depreciation and
amortization 36.9 17.5 54.4 33.6 17.3 50.9 36.6 17.1 53.7
EBITDA 132.9 26.6 159.5 117.1 31.2 148.3 91.0 32.3 123.3
Special items, before
tax 2.4 — 2.4 14.2 — 14.2 19.9 — 19.9
Depreciation included
in special items (0.6) — (0.6) 1.4 — 1.4 (0.9) — (0.9)
Adjusted EBITDA $ 134.7 $ 26.6 $ 161.3 $ 132.7 $ 31.2 $ 163.9 $ 110.0 $ 32.3 $ 142.3
Reconciliation of Avient consolidated pro forma EBITDA
Q4 2021 YTD 2021
Avient
Pro
forma
APM
Pro
forma
Avient Avient
Pro
forma
APM
Pro
forma
Avient
Net income from continuing operations 11.2 2.5 13.7 155.2 1.6 156.8
Income tax expense 16.2 (1.9) 14.3 48.3 3.7 52.0
Interest expense 17.5 11.1 28.6 75.3 44.6 119.9
Depreciation and amortization 37.9 18.9 56.8 145.0 70.8 215.8
EBITDA 82.8 30.6 113.4 423.8 120.7 544.5
Special items, before tax 20.6 — 20.6 57.1 — 57.1
Depreciation included in special items (1.6) — (1.6) (1.7) — (1.7)
Adjusted EBITDA $ 101.8 $ 30.6 $ 132.4 $ 479.2 $ 120.7 $ 599.9
3
Reconciliation of Avient consolidated pro forma EBITDA
Q1 2022 Q2 2022
Avient
Pro
forma
APM
Pro
forma
Avient Avient
Pro
forma
APM
Pro
forma
Avient
Net income from continuing operations 64.7 2.6 67.3 62.8 5.2 68.0
Income tax expense 20.0 1.7 21.7 22.7 1.4 24.1
Interest expense 16.9 11.1 28.0 16.2 11.1 27.3
Depreciation and amortization 37.6 16.6 54.2 36.3 16.6 52.9
EBITDA 139.2 32.0 171.2 138.0 34.3 172.3
Special items, before tax 6.6 — 6.6 0.9 — 0.9
Depreciation included in special items (2.1) — (2.1) (1.1) — (1.1)
Adjusted EBITDA $ 143.7 $ 32.0 $ 175.7 $ 137.8 $ 34.3 $ 172.1
Reconciliation of Specialty Engineered Pro Forma Sales
Q1 2021 Q2 2021 Q3 2021 Q4 2021 YTD 2021 Q1 2022 Q2 2022
Sales 214.7 238.9 231.7 226.3 911.6 243.1 242.3
Pro forma APM 98.9 108.8 93.8 94.9 396.4 94.8 100.5
Pro forma sales $ 313.6 $ 347.7 $ 325.5 $ 321.2 $ 1,308.0 $ 337.9 $ 342.8
Reconciliation of Avient Pro Forma Sales
Q1 2021 Q2 2021 Q3 2021 Q4 2021 YTD 2021 Q1 2022 Q2 2022
Sales 826.0 864.5 818.0 807.1 3,315.6 892.2 891.0
Pro forma APM 98.9 108.8 93.8 94.9 396.4 94.8 100.5
Pro forma sales $ 924.9 $ 973.3 $ 911.8 $ 902.0 $ 3,712.0 $ 987.0 $ 991.5
4
IR Slides
V17 - 9.26 324pm IR Deck - AVNT-2022.09.27 Pre Release v2
https://www.avient.com/sites/default/files/resources/PolyOne%2520IR%2520Presentation%2520-%2520RW%2520Baird%2520Global%2520Industrial%2520Conference.pdf
Use of Non-GAAP Measures
4POLYONE CORPORATION
INPUTS
FORMULATION
EXPERTISE
SERVICE VALUE
Base resins
Additives
Modifiers
Pigments
Expertise in
Polymer
Materials,
Services and
Solutions
OEMs
Brand Owners
Processers
Assemblers
InVisiO
SM
Color
Services
IQ Design Labs
LSS Customer
First
Specialty products & services
What We Do
Driving customer value
5POLYONE CORPORATION
$0.13
$0.68
$0.82
$1.00
$1.31
$1.80
$1.96
$2.06
2009 2010 2011 2012 2013 2014 2015 2016*
*Recast for DSS in discontinued operations
PolyOne At a Glance
Performance
Products &
Solutions
22%
PolyOne
Distribution
34%
Specialty
Engineered
Materials
18%
Color
Additives
and Inks
26%
2016
Revenue by
Segment
Adjusted Earnings per Share
2016
Revenue by
Geography
United
States
60%
Europe
15%
Latin
America
9%
Canada
7%
Asia
10%
6POLYONE CORPORATION
2%
43%
76%
0%
20%
40%
60%
80%
100%
2005 2010 3Q 2017
%
o
f
O
p
e
ra
ti
n
g
I
n
c
o
m
e
*
*Operating Income excludes corporate charges and special items **LTM 3Q 2017
Specialty OI $5M $87M $275M**
JV’s Performance Products & Solutions
Specialty MixDistribution
Mix Shift Highlights Specialty Transformation
Distribution and Contract
Manufacturing Businesses
7POLYONE CORPORATION
2014 2015 2016 2017
2014 2015 2016 2017
Driving Growth
• Refreshed training curriculum
for sales force
• Upgraded capabilities to generate
and capture new business leads
• Expanded R&D resources to focus
on key platforms
2014 2015 2016 2017
Investment in Commercial Resources
Commercial Resource Additions*
Total Sales CallsSales Opportunity Funnel (in billions)
*Sales, Marketing & Technology headcount
8POLYONE CORPORATION
*ROIC is defined as TTM adjusted OI after tax divided by the sum of average debt and equity less cash over a 5 quarter period
Proof of Performance & 2020 Platinum Vision
20%+
20%+
12 - 14%
6.5 – 7.5%
15%
Consistently Deliver Double Digit Annual EPS Growth
2006 YTD 2017 2020
“Where we were” “Where we are” Platinum Vision
ROIC* 5.0% 13.8%
Operating Income % of Sales
Color, Additives & Inks 1.7% 16.4%
Specialty Engineered Materials 1.1% 13.1%
Performance Products & Solutions 5.5% 11.4%
Distribution 2.6% 6.6%
9POLYONE CORPORATION
$50
$116
$137
$0
$40
$80
$120
$160
$200
2012 2014 2016 2017
10.8%
11.3%
12.9%
13.8%
10.0%
11.0%
12.0%
13.0%
14.0%
15.0%
2012 2014 2016 3Q 2017 2020
Platinum
Vision
Free Cash Flow
(in millions)
ROIC*
*ROIC is defined as TTM adjusted OI after tax divided by the sum of average debt and equity less cash over a 5 quarter period
Free Cash Flow and Improving Returns
15.0%
>$200
10POLYONE CORPORATION
$0.16
$0.20
$0.24
$0.32
$0.40
$0.48
$0.54
$0.70
$-
$0.10
$0.20
$0.30
$0.40
$0.50
$0.60
$0.70
$0.80
$0.90
$1.00
2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
Annual Dividend
7 Consecutive Years of Increased Dividends
3-Year Dividend Plan
Announced 30% increase
to dividend in October
2017, reflecting strong and
sustainable cash flow as
well as confidence in future
earnings growth
Expect to increase annual
dividend 60% or more
cumulatively over next
three years
11POLYONE CORPORATION
$767M
Returning Cash to Shareholders
$0
$150
$300
$450
$600
$750
2011 2012 2013 2014 2015 2016 3Q
2017
Cumulative Share Repurchases
(in millions)
Since 2011, we have
returned over $950 million
to shareholders
$192 million returned
through dividends
$767 million returned
through share
repurchases
Have repurchased 20.8
million shares since
early 2013
$767M
12POLYONE CORPORATION
Expanding our sales,
marketing, and
technical capabilities
Investing in
operational and LSS
initiatives
~60 - 70% of capital
expenditures fund
growth initiatives
Organic
Growth
Acquisitions
Share
Repurchases
Dividends
Targets that expand
our:
• Specialty
offerings
• End market
presence
• Geographic
breadth
Growth synergies
Adjacent material
solutions
Repurchased 2.0
million shares
YTD 2017
Repurchased 20.8
million shares
since early 2013
6.5 million shares
are available for
repurchase under
the current
authorization
Increased annual
dividend by 30% to
$0.70 per share,
representing the
seventh consecutive
year of dividend
growth
Free Cash Flow and Strong Balance Sheet
Fund Investment / Shareholder Return
13POLYONE CORPORATION
*Specialty Platform revenue from products introduced in last five years
Vitality Index Progression*
12%
42%
2006 2016
Target ≥ 35%
Innovation Drives Earnings Growth
Innovation Pipeline Potential
$20
$54
2006 2016
Research & Development Spending
($ millions)
Phase 1
Frame
Opportunity
12 Projects
Phase 2
Build Business
Case
10 Projects
Phase 3
Prototype
21 Projects
Phase 4
Scale-up &
Test Market
19 Projects
Phase 5
Commercial
Launch
10 Projects
$500 Million $1.4 Billion $700 Million
Total Specialty Addressable Market of over $2.6 Billion
14POLYONE CORPORATION
Key Innovation Growth Drivers
Composites
Barrier Additive
Technology
Fiber Colorants
Flame Retardant
Polymers
Increasing regulatory drive for halogen replacements
$400m addressable market
Drive to prevent oxygen, light and UV rays from affecting contents in PET
packaging, extending shelf life
$200m addressable market
60% of world fiber consumption is synthetic, need to simplify manufacturing
and eliminate waste
$300m addressable market
Polymer formulation and process engineering create a pipeline for next
generation materials
Drive to replace aluminum and steel with plastics without
compromising on strength
15POLYONE CORPORATION
Providing LSS services to
small/medium sized customers
54% of associates trained in LSS, with over
125 active black belts
Have trained over 30 customers in
LSS methodology
Providing training in Customer Centric
Selling Skills with customers
Providing Industrial design and color
services to small/medium sized
customers
On time delivery above 95%
Strengthening relationships:
Customer First Through World-Class Service
16POLYONE CORPORATION
Addressable market exceeds $40 billion
Strong performance demonstrates that our strategy and execution are
working
Megatrends and emerging opportunities align with strengths
Innovation and services provide differentiation, incremental pricing
power and competitive advantage
Strategic reinvestment for growth while returning cash to shareholders
Strong and proven management team driving growth
and performance
Why Invest In PolyOne?
https://www.avient.com/sites/default/files/resources/Universal_Polyamide_Overmold_Thermoplastic_Elastomer.pdf
Page 8 of 11
0
0.5
1
1.5
2
2.5
3
3.5
4
P
ee
l f
or
ce
, N
/m
m
60
A
-I
60
A
-II
75
A
-II
I
55
A
-IV
65
A
-V
50
A
-V
I
70
A
-V
II
TPE Grade
Capron 8333GHI
260C
276C
288C
Figure4.
Page 9 of 11
0
0.5
1
1.5
2
2.5
3
3.5
4
P
ee
l f
or
ce
, N
/m
m
60
A
-I
60
A
-II
75
A
-II
I
55
A
-IV
65
A
-IV
50
A
-V
I
70
A
-V
II
TPE Grade
Zytel 70G33L
260C
276C
288C
Figure 6.
Page 10 of 11
0
0.5
1
1.5
2
2.5
3
3.5
4
4.5
P
ee
l f
or
ce
, N
/m
m
60
A
-I
60
A
-II
75
A
-II
I
55
A
-IV
65
A
-IV
50
A
-V
I
70
A
-V
II
TPE Grade
Zytel 409AHS
260C
276C
288C
Figure 8.
https://www.avient.com/resource-center?document_type=59&document_subtype=0&industry=0&product_family=0&product_name=0&op=FILTER RESULTS&form_id=resource_filter_form&page=13
Maxxam™ BIO Bio-Based Polyolefins
https://www.avient.com/resource-center?document_type=59&page=13
Maxxam™ BIO Bio-Based Polyolefins
https://www.avient.com/resource-center?document_subtype=0&document_type=59&form_id=resource_filter_form&industry=0&op=FILTER RESULTS&product_family=0&product_name=0&page=13
Maxxam™ BIO Bio-Based Polyolefins
https://www.avient.com/resource-center?document_subtype=0&document_type=59&form_id=resource_filter_form&industry=0&op=FILTER RESULTS&product_family=0&product_name=0&page=6
Maxxam™ REC formulation maintains performance requirements while incorporating recycled content